Mild hyperhomocysteinemia has been identified as a risk factor for arterial disease and for venous thrombosis. Individuals homozygous for the thermolabile variant of the methylene tetrahydrofolate reductase gene (MTHFR) which results from a common mutation Ala677 → Val and is found in 5-15% of the general population, have significantly elevated plasma homocysteine levels and may account for one of the genetic risk factors in vascular disease. We have analyzed the prevalence of MTHFR-T homozygotes in patients with arterial disease or venous thrombosis. We studied 191 patients with arterial disease and 127 individuals with venous thrombosis and compared with 296 unmatched controls. The results showed that there was a high prevalence of homozygotes for the mutated MTHFR-T allele among a group of patients with arterial disease (19%) in the absence of hyperlipoproteinemia, hypertension, and diabetes mellitus when compared to controls (4%), odds ratio of 5.52 (95% C.I., 2.27 to 13.51). The prevalence of homozygotes among patients with venous thrombosis was 11%, odds ratio of 2.93 (95% C.I., 1.23 to 7.01). The risk of venous thrombosis remained high, odds ratio of 2.63, even after we excluded 27 patients with hereditary thrombophilia (e.g. factor V Leiden, dysfibrinogenemia, deficiency of protein C, protein S, antithrombin III, or factor XII) from the 127 overall cases with venous thrombosis. These data support the hypothesis that being a homozygote for the MTHFR-T is a risk factor for the development of arterial diasease and also for venous thrombosis.775818821Ueland, P.M., Refsum, H., Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy (1989) J Lab Clin Med, 114, pp. 473-501Kang, S.S., Wong, P.W.K., Malinow, M.R., Hyperhomocysteinemia as a risk factor for occlusive vascular disease (1992) Annu Rev Nutr, 12, pp. 279-298Brattström, L., Lindgren, A., Hyperhomocysteinemia as a risk factor for stroke (1992) Neurol Res, 14, pp. 81-84Verhoef, P., Hennekens, C.H., Malinow, R., Kok, F.J., Willet, W.C., Stampfer, M.J., A prospective study of plasma homocysteine and risk of ischemic stroke (1994) Stroke, 25, pp. 1924-1930Boers, G.H.J., Smals, A.G.H., Trijbels, F.J.M., Fowler, B., Bakkeren, J.A.J.M., Schoonderwaldt, H.C., Kleijer, W.J., Kloppenborg, P.W.C., Heterozygosity for homocystinuria in peripheral and cerebral occlusive arterial disease (1985) N Engl J Med, 313, pp. 709-715Boushey, C.J., Beresford, S.S.A., Omenn, G.S., Motulsky, A.G., A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes (1995) JAMA, 274, pp. 1049-1057Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., Graham, I., Hyperhomocysteinemia: An independent risk factor for vascular disease (1991) N Engl J Med, 324, pp. 1149-1155Falcon, C.R., Cattaneo, M., Panzeri, D., Martinelli, I., Mannucci, P.M., High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis (1994) Arterioscler Thromb, 14, pp. 1080-1083Den Heijer, M., Blom, H.J., Gerrits, W.B.J., Rosendaal, F.R., Haak, H.L., Wijermans, P.W., Bos, G.M.J., Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? (1995) Lancet, 345, pp. 882-885Den Heijer, M., Koster, T., Blom, H.J., Bos, G.M.J., Briët, E., Reitsma, P.H., Vandenbroucke, J.P., Rosendaal, F.R., Hyperhomocysteinemia as a risk factor for deep-vein thrombosis (1996) N Engl J Med, 334, pp. 759-762Ubbink, J.B., Vermaak, W.J.H., Van Der Merwe, A., Becker, P.J., Vitamin B 12, vitamin B 6, and folate nutritional status in men with hyperhomocysteinemia (1993) Am J Clin Nutr, 57, pp. 47-53Stabler, S.P., Marcell, P.D., Podell, E.R., Allen, R.H., Savage, D.G., Lindenbaum, J., Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry (1988) J Clin Invest, 81, pp. 466-474Kraus, J.P., Molecular basis of phenotype expression in homocystinuria (1994) J Inherit Metab Dis, 17, pp. 383-390Daly, L., Robinson, K., Tan, K.S., Graham, I., Hyperhomocysteinemia: A metabolic risk factor for coronary heart disease determined by both genetic and environmental influences? (1993) Q J Med, 86, pp. 685-689Mudd, S.H., Havlik, Rb., Levy, H.L., McKusick, V.A., Feinleib, M., A study of cardiovascular risk in heterozygotes for homocystinuria (1981) Am J Hum Genet, 33, pp. 883-893Engbersen, A.M.T., Franken, D.G., Boers, G.H.J., Stevens, E.M.B., Trijbels, F.J.M., Blom, H.J., Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia (1995) Am J Hum Genet, 56, pp. 142-150Goyette, P., Frosst, P., Rosenblatt, D.S., Rozen, R., Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency (1995) Am J Hum Genet, 56, pp. 1052-1059Kang, S.S., Wong, P.W.K., Susmano, A., Sora, J., Norusis, M., Ruggie, N., Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease (1991) Am J Hum Genet, 48, pp. 536-545Kang, S.S., Wong, P.W.K., Zhou, J., Sora, J., Lessick, M., Ruggie, N., Grcevich, G., Thermolabile methylenetetrahydrofolate reductase in patients with coronay artery disease (1988) Metabolism, 37, pp. 611-613Kang, S.S., Zhou, J., Wong, P.W.K., Kowalisyn, J., Strokosch, G., Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase (1988) Am J Hum Genet, 43, pp. 414-421Franken, D.G., Boers, G.H.J., Blom, H.J., Trijbels, J.M.F., Kloppernborg, P.W.C., Treatment of mild hyperhomocysteinemia in vascular disease patients (1994) Arterioscler Thromb, 14, pp. 465-470Froost, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.H.J., Rozen, R., A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahidrofolate reductase (1995) Nature Genetics, 10, pp. 111-113Kluijtmans, L.A.J., Van Den Heuvel, L.P.W.J., Boers, G.H.J., Frosst, P., Stevens, E.M.B., Van Oost, B.A., Den Heijer, M., Rozen, Rl., Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease (1996) Am J Human Genet, 58, pp. 35-41Motulsky, A.G., Nutritional ecogenetics: Homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid (1996) Am J Hum Genet, 58, pp. 17-20Ubbink, J.B., Vermaak, W.J.H., Delport, R., Van Der Merwe, A., Becker, P.J., Potgieter, H., Effective homocysteine metabolism may protect South African blacks against coronary heart disease (1995) Am J Clin Nutr, 62, pp. 802-808Stein, E.A., Lipids, Lipoproteins, and Apolipoprotrein (1987) Fundamentals of Clinical Chemistry, pp. 449-481. , Tieftz NW, editor. Philadelphia, PA: W. B. SaundersGuidelines on testing for the lupus anticoagulant (1991) J Clin Pathol, 44, pp. 885-889Arruda, V.R., Annichino-Bizzacchi, J.M., Costa, F.F., Reitsma, F.F., Factor V Leiden (FVQ506) is common in Brazilian population (1995) Am J Hematol, 39, pp. 242-243Wolf, M., Boyer-Neumann, C., Martinoli, J.-L., A new functional assay for human protein S activity using activated factor V as substrate (1989) Thromb Haemost, 62, pp. 1144-1145Odegaard, O.R., Try, K., Abilgaard, U., Protein C: A simplified semi-automated activity assay (1986) Thromb Res, 42, pp. 257-262Abildgaard, U., Lie, M., Oldergaard, O.R., Antithrombin (heparin cofactor) assay with new chromogenic substrates (1977) Thromb Res, 11, pp. 549-553Bowie, E.J.W., Owen, J.C.A., Clinical and laboratory diagnosis of hemorrhagic disorders (1991) Disorders of Hemostasis, pp. 48-74. , Ratnoff OD, Forbes CD, editors. Philadelphia: W. B. Saunders CompanyMillar, S.A., Dykes, D.D., Polesky, H.F., A simple salting out procedure for extracting DNA from nucleated cell (1988) Nucleic Acids Res, 16, p. 1215Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B., Erlich, H.A., Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase (1988) Science, 239, pp. 487-491Dean, A.G., Dean, J.A., Coulombier, D., Brendel, K.A., Smith, D.C., Burton, A.H., Dicker, R.C., Arner, T.G., (1994) Epi Info, Version 6: A Word Processing, Database, and Statistics Program for Epidemiology on Microcomputers, , Atlanta: Center for Disease Control and PreventionWilcken, D.E.L., Wang, X.L., Sim, A.S., McCredie, Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation (1996) Arterioscler Thromb Vase Biol, 16, pp. 878-882